期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Extrahepatic right portal vein ligation allows parenchyma-sparing en bloc resection of segments 7, 8 and 4a for liver tumors engaging the right and middle hepatic veins 被引量:1
1
作者 Charalampos Farantos Nikolaos Arkadopoulos +4 位作者 Pantelis Vassiliu Panagiotis Kokoropoulos Nikolaos Economopoulos Aggeliki Pandazi Vassilis Smyrniotis 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2015年第5期539-542,共4页
Right trisectionectomy for posterior liver tumors engaging the right and middle hepatic veins may lead to post-hepatectomy liver failure if the anticipated liver remnant is small. In such patients we developed a paren... Right trisectionectomy for posterior liver tumors engaging the right and middle hepatic veins may lead to post-hepatectomy liver failure if the anticipated liver remnant is small. In such patients we developed a parenchymasparing one-step approach, that includes extrahepatic right portal vein ligation accompanied by en bloc resection only of segments 7, 8 and 4a and resection of the right and middle hepatic veins. The technique was applied in 3 patients with normal liver function, where according to the preoperative computed tomography the volume of segments 1, 2 and 3 ranged between 17% and 20% of the total liver volume. In all patients liver biochemistry improved rapidly postoperatively and a doubling of volume of segments 1, 2 and 3 was achieved by the third postoperative week, as extrahepatic right portal vein ligation ameliorated reperfusion injury of the remaining segments 5 and 6 and induced hypertrophy of segments 1, 2, 3 and 4b. There was no mortality or long-term complications.Patients are alive and free of disease 74, 50 and 17 months after the operation, respectively. We propose that the term "extended upper right sectionectomy" may be considered for the en bloc resection of segments 7, 8 and 4a, in future revisions ofthe Brisbane 2000 terminology of hepatic anatomy and resections. 展开更多
关键词 liver trisectionectomy extrahepatic right portal vein ligation parenchyma-sparing hepatectomy
下载PDF
Dual transformation therapy for giant hepatocellular carcinoma: Two case reports and review of literature
2
作者 Qiang Gao Guang-Zhi Zhu +4 位作者 Chuang-Ye Han Xin-Ping Ye Hua-Sheng Huang Shu-Tian Mo Tao Peng 《World Journal of Gastrointestinal Surgery》 SCIE 2023年第9期2089-2097,共9页
BACKGROUND In the translational therapy of giant hepatocellular carcinoma(HCC),hepatic arterial infusion chemotherapy(HAIC)combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors(TKI)after laparoscopic po... BACKGROUND In the translational therapy of giant hepatocellular carcinoma(HCC),hepatic arterial infusion chemotherapy(HAIC)combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors(TKI)after laparoscopic portal vein ligation(PVL)is extremely rare.This is a dual conversion therapy that combines surgery and oncology.Here,we report two cases of successful surgical completion after dual conversion therapy.CASE SUMMARY We report that a 54-year-old man and a 69-year-old woman were diagnosed with primary HCC combined with hepatitis B cirrhosis(case 2 also combined with fatty liver)on physical examination.Due to the insufficient residual liver volume assessed before surgery,laparoscopic right PVL was performed,followed by HAIC combined with anti-PD-1 immunotherapy and TKI.Finally,surgical resection was successfully completed,and pathology confirmed that the tumor was mostly necrotic(90%)in one case,and no live tumor tissue was found in the other case.CONCLUSION In the process of surgical transformation,our treatment plan takes into account the control and transformation of oncology at the same time,which is expected to provide more opportunities for radical hepatectomy and improve the prognosis of patients with large liver cancer. 展开更多
关键词 Giant hepatocellular carcinoma Laparoscopic right portal vein ligation hepatic arterial infusion chemotherapy Anti-PD-1 immunotherapy Tyrosine kinase inhibitor Case report
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部